Annual ROE
-730.48%
-542.13%-287.83%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual return on equity is -730.48%, with the most recent change of -542.13% (-287.83%) on December 31, 2023.
- During the last 3 years, CYTH annual ROE has fallen by -573.45% (-365.18%).
- CYTH annual ROE is now -600.71% below its all-time high of 145.89%, reached on December 31, 2002.
Performance
CYTH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
749.86%
-9511.50%-92.69%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly return on equity is 749.86%, with the most recent change of -9511.50% (-92.69%) on September 30, 2024.
- Over the past year, CYTH quarterly ROE has increased by +4737.13% (+118.81%).
- CYTH quarterly ROE is now -92.69% below its all-time high of 10.26 thousand%, reached on June 30, 2024.
Performance
CYTH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CYTH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -287.8% | +118.8% |
| 3 y3 years | -365.2% | +118.8% |
| 5 y5 years | -83.5% | +118.8% |
CYTH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -567.9% | at low | -92.7% | +118.5% |
| 5 y | 5-year | -567.9% | +6.5% | -92.7% | +104.7% |
| alltime | all time | -600.7% | +6.5% | -92.7% | +104.7% |
Cyclo Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 749.86%(-92.7%) |
| Jun 2024 | - | 10.26 K%(-353.0%) |
| Mar 2024 | - | -4056.09%(+1.7%) |
| Dec 2023 | -730.48%(+287.8%) | -3987.27%(+38.6%) |
| Sep 2023 | - | -2877.11%(+331.9%) |
| Jun 2023 | - | -666.19%(+116.2%) |
| Mar 2023 | - | -308.17%(+78.7%) |
| Dec 2022 | -188.35%(+72.2%) | -172.42%(+34.4%) |
| Sep 2022 | - | -128.27%(+14.0%) |
| Jun 2022 | - | -112.53%(+6.8%) |
| Mar 2022 | - | -105.36%(-12.7%) |
| Dec 2021 | -109.37%(-30.4%) | -120.67%(-26.8%) |
| Sep 2021 | - | -164.80%(-6.1%) |
| Jun 2021 | - | -175.59%(-30.0%) |
| Mar 2021 | - | -250.69%(-59.4%) |
| Dec 2020 | -157.03%(-79.9%) | -617.01%(-96.2%) |
| Sep 2020 | - | -16.08 K%(+1896.6%) |
| Jun 2020 | - | -805.39%(+32.2%) |
| Mar 2020 | - | -609.35%(+53.2%) |
| Dec 2019 | -781.18%(+96.3%) | -397.70%(+11.1%) |
| Sep 2019 | - | -357.88%(-17.3%) |
| Jun 2019 | - | -432.58%(-71.5%) |
| Mar 2019 | - | -1516.06%(+163.0%) |
| Dec 2018 | -398.01%(+38.7%) | -576.50%(+0.8%) |
| Sep 2018 | - | -571.70%(+42.9%) |
| Jun 2018 | - | -399.97%(+44.4%) |
| Mar 2018 | - | -277.01%(+12.7%) |
| Dec 2017 | -286.95%(+79.1%) | -245.81%(+35.0%) |
| Sep 2017 | - | -182.09%(+1.0%) |
| Jun 2017 | - | -180.32%(+5.9%) |
| Mar 2017 | - | -170.29%(+17.1%) |
| Dec 2016 | -160.25%(+154.9%) | -145.47%(+16.4%) |
| Sep 2016 | - | -124.97%(+33.2%) |
| Jun 2016 | - | -93.84%(+25.8%) |
| Mar 2016 | - | -74.62%(+20.2%) |
| Dec 2015 | -62.88%(+227.0%) | -62.07%(+46.6%) |
| Sep 2015 | - | -42.33%(+30.0%) |
| Jun 2015 | - | -32.56%(+11.6%) |
| Mar 2015 | - | -29.17%(+60.2%) |
| Dec 2014 | -19.23%(-256.9%) | -18.21%(+39.5%) |
| Sep 2014 | - | -13.05%(+24.2%) |
| Jun 2014 | - | -10.51%(-211.3%) |
| Mar 2014 | - | 9.44%(-18.7%) |
| Dec 2013 | 12.26%(+145.7%) | 11.61%(-53.3%) |
| Sep 2013 | - | 24.85%(-15.4%) |
| Jun 2013 | - | 29.36%(+197.5%) |
| Mar 2013 | - | 9.87%(+93.5%) |
| Dec 2012 | 4.99% | 5.10%(-157.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | -8.95%(-3.6%) |
| Jun 2012 | - | -9.28%(+218.9%) |
| Mar 2012 | - | -2.91%(-57.6%) |
| Dec 2011 | -6.92%(+140.3%) | -6.87%(-341.1%) |
| Sep 2011 | - | 2.85%(-27.1%) |
| Jun 2011 | - | 3.91%(+18.8%) |
| Mar 2011 | - | 3.29%(-213.4%) |
| Dec 2010 | -2.88%(-82.4%) | -2.90%(-88.8%) |
| Sep 2010 | - | -25.83%(+25.0%) |
| Jun 2010 | - | -20.66%(-14.5%) |
| Mar 2010 | - | -24.15%(+13.3%) |
| Dec 2009 | -16.36%(-50.1%) | -21.32%(-28.2%) |
| Sep 2009 | - | -29.69%(-6.2%) |
| Jun 2009 | - | -31.64%(+2.9%) |
| Mar 2009 | - | -30.74%(-0.5%) |
| Dec 2008 | -32.76%(-148.2%) | -30.88%(-193.3%) |
| Sep 2008 | - | 33.09%(-24.1%) |
| Jun 2008 | - | 43.60%(-27.9%) |
| Mar 2008 | - | 60.47%(-25.3%) |
| Dec 2007 | 67.95%(-479.6%) | 80.95%(+231.2%) |
| Sep 2007 | - | 24.44%(+468.4%) |
| Jun 2007 | - | 4.30%(-131.5%) |
| Mar 2007 | - | -13.66%(-23.2%) |
| Dec 2006 | -17.90%(-40.5%) | -17.79%(-73.2%) |
| Sep 2006 | - | -66.33%(+5.6%) |
| Jun 2006 | - | -62.82%(+17.0%) |
| Mar 2006 | - | -53.70%(+127.2%) |
| Dec 2005 | -30.10%(-69.6%) | -23.64%(+71.2%) |
| Sep 2005 | - | -13.81%(+597.5%) |
| Jun 2005 | - | -1.98%(-96.5%) |
| Mar 2005 | - | -57.14%(-45.2%) |
| Dec 2004 | -99.01%(-238.9%) | -104.20%(+508.3%) |
| Sep 2004 | - | -17.13%(+10.0%) |
| Jun 2004 | - | -15.57%(-121.8%) |
| Mar 2004 | - | 71.50%(-27.1%) |
| Dec 2003 | 71.27%(-51.1%) | 98.03%(+2571.1%) |
| Sep 2003 | - | 3.67%(-89.8%) |
| Jun 2003 | - | 36.09%(-40.6%) |
| Mar 2003 | - | 60.73%(-50.6%) |
| Dec 2002 | 145.89%(-176.4%) | 122.88%(-17.5%) |
| Sep 2002 | - | 148.98%(+529.4%) |
| Jun 2002 | - | 23.67%(-150.2%) |
| Mar 2002 | - | -47.19%(-71.0%) |
| Dec 2001 | -191.05%(-46.0%) | -162.78%(+19.7%) |
| Sep 2001 | - | -136.02%(+5.3%) |
| Jun 2001 | - | -129.23%(+11.1%) |
| Mar 2001 | - | -116.28%(+53.5%) |
| Dec 2000 | -354.12% | -75.77%(+325.0%) |
| Sep 2000 | - | -17.83% |
FAQ
- What is Cyclo Therapeutics annual return on equity?
- What is the all time high annual ROE for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual ROE year-on-year change?
- What is Cyclo Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly ROE year-on-year change?
What is Cyclo Therapeutics annual return on equity?
The current annual ROE of CYTH is -730.48%
What is the all time high annual ROE for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual return on equity is 145.89%
What is Cyclo Therapeutics annual ROE year-on-year change?
Over the past year, CYTH annual return on equity has changed by -542.13% (-287.83%)
What is Cyclo Therapeutics quarterly return on equity?
The current quarterly ROE of CYTH is 749.86%
What is the all time high quarterly ROE for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly return on equity is 10.26 K%
What is Cyclo Therapeutics quarterly ROE year-on-year change?
Over the past year, CYTH quarterly return on equity has changed by +4737.13% (+118.81%)